Earnings Scheduled For February 9, 2023
Companies Reporting Before The Bell
• AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.
What 4 Analyst Ratings Have To Say About Ventas
Within the last quarter, Ventas (NYSE:VTR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Keybanc Maintains Overweight on Ventas, Lowers Price Target to $55
Keybanc analyst Austin Wurschmidt maintains Ventas (NYSE:VTR) with a Overweight and lowers the price target from $56 to $55.
Ventas Inc. REIT: Relief Rally Gains New Strength
While quite a few real estate investment trusts (REITs) are just now coming off of new lows, Ventas Inc. (NYSE: VTR) is up to a three-month high.
These 2 High-Yield Healthcare REITs Are Holding Up Better Than The Overall Market In 2022
Real estate investment trusts (REITs) operating in the healthcare sector, tend to have a trailing 10-year return of 11.6%, according to SP Global.
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Expert Ratings for Ventas
Analysts have provided the following ratings for Ventas (NYSE:VTR) within the last quarter:
7 Analysts Have This to Say About Ventas
Within the last quarter, Ventas (NYSE:VTR) has observed the following analyst ratings:
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 528 companies set new 52-week lows.